BlackRock Investment Management, LLC - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 36 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$14,000
+180.0%
2,6500.0%0.00%
Q3 2016$5,0000.0%2,650
+15.9%
0.00%
Q2 2016$5,0000.0%2,2870.0%0.00%
Q1 2016$5,000
-28.6%
2,2870.0%0.00%
Q4 2015$7,000
-30.0%
2,2870.0%0.00%
Q3 2015$10,000
-16.7%
2,2870.0%0.00%
Q2 2015$12,0000.0%2,287
+40.0%
0.00%
Q1 2015$12,000
+9.1%
1,6330.0%0.00%
Q4 2014$11,0000.0%1,633
-7.3%
0.00%
Q3 2014$11,000
-26.7%
1,761
+8.4%
0.00%
Q2 2014$15,000
-89.6%
1,625
-90.8%
0.00%
Q1 2014$144,000
+39.8%
17,700
+10.3%
0.00%
Q4 2013$103,000
+9.6%
16,042
+70.8%
0.00%
Q3 2013$94,0009,3920.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 1,192,080$9,704,0004.11%
Ghost Tree Capital, LLC 219,977$1,790,0001.06%
JBF Capital, Inc. 148,178$1,205,0000.18%
Polar Capital LLP 900,604$7,326,0000.17%
SPHERA FUNDS MANAGEMENT LTD. 80,000$651,0000.15%
HAMILTON LANE ADVISORS LLC 33,141$270,0000.11%
Jasper Ridge Partners, L.P. 63,996$521,0000.03%
Weiss Multi-Strategy Advisers LLC 95,000$773,0000.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 550,000$4,474,0000.01%
AXA S.A. 292,625$2,381,0000.01%
View complete list of CONATUS PHARMACEUTICALS INC shareholders